vs
Side-by-side financial comparison of Hologic (HOLX) and WillScot Holdings Corp (WSC). Click either name above to swap in a different company.
Hologic is the larger business by last-quarter revenue ($1.0B vs $566.0M, roughly 1.9× WillScot Holdings Corp). Hologic runs the higher net margin — 17.1% vs -33.1%, a 50.2% gap on every dollar of revenue. On growth, Hologic posted the faster year-over-year revenue change (2.5% vs -6.1%). Hologic produced more free cash flow last quarter ($215.2M vs $149.7M). Over the past eight quarters, Hologic's revenue compounded faster (1.5% CAGR vs -1.8%).
Hologic, Inc. is an American medical technology company primarily focused on women's health; it sells medical devices for diagnostics, surgery, and medical imaging.
WillScot Holdings Corp is a leading provider of modular space solutions and portable storage services across North America. It serves a wide range of sectors including construction, commercial development, education, healthcare, government projects, and special events, offering flexible, scalable temporary and semi-permanent space solutions tailored to diverse client needs.
HOLX vs WSC — Head-to-Head
Income Statement — Q1 FY2026 vs Q4 FY2025
| Metric | | |
|---|---|---|
| Revenue | $1.0B | $566.0M |
| Net Profit | $179.1M | $-187.3M |
| Gross Margin | 56.0% | 50.4% |
| Operating Margin | 22.6% | -32.5% |
| Net Margin | 17.1% | -33.1% |
| Revenue YoY | 2.5% | -6.1% |
| Net Profit YoY | -10.9% | -310.0% |
| EPS (diluted) | $0.79 | $-1.02 |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q4 25 | $1.0B | $566.0M | ||
| Q3 25 | $1.0B | $566.8M | ||
| Q2 25 | $1.0B | $589.1M | ||
| Q1 25 | $1.0B | $559.6M | ||
| Q4 24 | $1.0B | $602.5M | ||
| Q3 24 | $988.0M | $601.4M | ||
| Q2 24 | $1.0B | $604.6M | ||
| Q1 24 | $1.0B | $587.2M |
| Q4 25 | $179.1M | $-187.3M | ||
| Q3 25 | $187.2M | $43.3M | ||
| Q2 25 | $194.9M | $47.9M | ||
| Q1 25 | $-17.4M | $43.1M | ||
| Q4 24 | $201.0M | $89.2M | ||
| Q3 24 | $178.6M | $-70.5M | ||
| Q2 24 | $194.5M | $-46.9M | ||
| Q1 24 | $169.9M | $56.2M |
| Q4 25 | 56.0% | 50.4% | ||
| Q3 25 | 55.6% | 49.7% | ||
| Q2 25 | 56.3% | 50.3% | ||
| Q1 25 | 37.5% | 53.7% | ||
| Q4 24 | 56.8% | 55.8% | ||
| Q3 24 | 56.4% | 53.5% | ||
| Q2 24 | 55.4% | 54.1% | ||
| Q1 24 | 53.3% | 54.0% |
| Q4 25 | 22.6% | -32.5% | ||
| Q3 25 | 22.6% | 21.0% | ||
| Q2 25 | 24.9% | 21.5% | ||
| Q1 25 | -0.7% | 21.3% | ||
| Q4 24 | 22.5% | 28.9% | ||
| Q3 24 | 23.3% | -5.9% | ||
| Q2 24 | 24.1% | -0.9% | ||
| Q1 24 | 20.7% | 22.1% |
| Q4 25 | 17.1% | -33.1% | ||
| Q3 25 | 17.8% | 7.6% | ||
| Q2 25 | 19.0% | 8.1% | ||
| Q1 25 | -1.7% | 7.7% | ||
| Q4 24 | 19.7% | 14.8% | ||
| Q3 24 | 18.1% | -11.7% | ||
| Q2 24 | 19.2% | -7.7% | ||
| Q1 24 | 16.7% | 9.6% |
| Q4 25 | $0.79 | $-1.02 | ||
| Q3 25 | $0.84 | $0.24 | ||
| Q2 25 | $0.86 | $0.26 | ||
| Q1 25 | $-0.08 | $0.23 | ||
| Q4 24 | $0.87 | $0.48 | ||
| Q3 24 | $0.75 | $-0.37 | ||
| Q2 24 | $0.82 | $-0.25 | ||
| Q1 24 | $0.72 | $0.29 |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | $2.4B | $14.6M |
| Total DebtLower is stronger | $2.5B | $3.6B |
| Stockholders' EquityBook value | $5.2B | $856.3M |
| Total Assets | $9.2B | $5.8B |
| Debt / EquityLower = less leverage | 0.48× | 4.15× |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $2.4B | $14.6M | ||
| Q3 25 | $2.2B | $14.8M | ||
| Q2 25 | $1.9B | $12.8M | ||
| Q1 25 | $1.6B | $10.7M | ||
| Q4 24 | $2.0B | $9.0M | ||
| Q3 24 | $2.3B | $11.0M | ||
| Q2 24 | $2.4B | $5.9M | ||
| Q1 24 | $2.2B | $13.1M |
| Q4 25 | $2.5B | $3.6B | ||
| Q3 25 | $2.5B | $3.6B | ||
| Q2 25 | $2.5B | $3.7B | ||
| Q1 25 | $2.5B | $3.6B | ||
| Q4 24 | $2.5B | $3.7B | ||
| Q3 24 | $2.5B | $3.6B | ||
| Q2 24 | $2.5B | $3.5B | ||
| Q1 24 | $2.6B | $3.5B |
| Q4 25 | $5.2B | $856.3M | ||
| Q3 25 | $5.0B | $1.1B | ||
| Q2 25 | $4.8B | $1.0B | ||
| Q1 25 | $4.6B | $1.0B | ||
| Q4 24 | $4.8B | $1.0B | ||
| Q3 24 | $5.1B | $1.1B | ||
| Q2 24 | $5.0B | $1.2B | ||
| Q1 24 | $4.8B | $1.3B |
| Q4 25 | $9.2B | $5.8B | ||
| Q3 25 | $9.0B | $6.1B | ||
| Q2 25 | $8.8B | $6.1B | ||
| Q1 25 | $8.5B | $6.0B | ||
| Q4 24 | $8.7B | $6.0B | ||
| Q3 24 | $9.2B | $6.0B | ||
| Q2 24 | $8.9B | $6.0B | ||
| Q1 24 | $8.7B | $6.2B |
| Q4 25 | 0.48× | 4.15× | ||
| Q3 25 | 0.50× | 3.39× | ||
| Q2 25 | 0.52× | 3.55× | ||
| Q1 25 | 0.55× | 3.56× | ||
| Q4 24 | 0.53× | 3.62× | ||
| Q3 24 | 0.49× | 3.42× | ||
| Q2 24 | 0.51× | 2.88× | ||
| Q1 24 | 0.53× | 2.63× |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | $229.9M | $158.9M |
| Free Cash FlowOCF − Capex | $215.2M | $149.7M |
| FCF MarginFCF / Revenue | 20.5% | 26.5% |
| Capex IntensityCapex / Revenue | 1.4% | 1.6% |
| Cash ConversionOCF / Net Profit | 1.28× | — |
| TTM Free Cash FlowTrailing 4 quarters | $1.0B | $737.7M |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $229.9M | $158.9M | ||
| Q3 25 | $355.1M | $191.2M | ||
| Q2 25 | $343.3M | $205.3M | ||
| Q1 25 | $169.4M | $206.6M | ||
| Q4 24 | $189.3M | $178.9M | ||
| Q3 24 | $367.0M | $-1.6M | ||
| Q2 24 | $405.8M | $175.6M | ||
| Q1 24 | $292.4M | $208.7M |
| Q4 25 | $215.2M | $149.7M | ||
| Q3 25 | $341.4M | $186.9M | ||
| Q2 25 | $330.5M | $199.0M | ||
| Q1 25 | $153.9M | $202.0M | ||
| Q4 24 | $172.5M | $176.6M | ||
| Q3 24 | $350.6M | $-4.9M | ||
| Q2 24 | $385.3M | $169.4M | ||
| Q1 24 | $279.6M | $202.1M |
| Q4 25 | 20.5% | 26.5% | ||
| Q3 25 | 32.5% | 33.0% | ||
| Q2 25 | 32.3% | 33.8% | ||
| Q1 25 | 15.3% | 36.1% | ||
| Q4 24 | 16.9% | 29.3% | ||
| Q3 24 | 35.5% | -0.8% | ||
| Q2 24 | 38.1% | 28.0% | ||
| Q1 24 | 27.5% | 34.4% |
| Q4 25 | 1.4% | 1.6% | ||
| Q3 25 | 1.3% | 0.7% | ||
| Q2 25 | 1.3% | 1.1% | ||
| Q1 25 | 1.5% | 0.8% | ||
| Q4 24 | 1.6% | 0.4% | ||
| Q3 24 | 1.7% | 0.6% | ||
| Q2 24 | 2.0% | 1.0% | ||
| Q1 24 | 1.3% | 1.1% |
| Q4 25 | 1.28× | — | ||
| Q3 25 | 1.90× | 4.41× | ||
| Q2 25 | 1.76× | 4.28× | ||
| Q1 25 | — | 4.80× | ||
| Q4 24 | 0.94× | 2.01× | ||
| Q3 24 | 2.05× | — | ||
| Q2 24 | 2.09× | — | ||
| Q1 24 | 1.72× | 3.71× |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
Revenue Breakdown by Segment
HOLX
| Molecular Diagnostics | $255.3M | 24% |
| Breast Imaging | $219.9M | 21% |
| Services | $216.4M | 21% |
| Capital Equipment Componentsand Software | $187.2M | 18% |
| Cytology Perinatal | $76.0M | 7% |
| Interventional Breast Solutions | $71.2M | 7% |
| Blood Screening | $8.4M | 1% |
| Other Typeof Revenue | $5.4M | 1% |
WSC
| Modular Space Leasing | $249.8M | 44% |
| Value Added Product And Services | $101.0M | 18% |
| Portable Storage Leasing | $83.0M | 15% |
| Delivery Revenue | $48.2M | 9% |
| Installation Revenue | $45.0M | 8% |
| Rental Units | $19.7M | 3% |
| New Units | $15.5M | 3% |
| Value Added Services | $10.3M | 2% |
| Other Leasing Related Products And Services | $3.8M | 1% |
